WESTPORT, Conn., Feb. 17, 2015 /PRNewswire/ -- TriStar
Wellness Solutions, Inc., (OTCQB: TWSI), a health and wellness
company that targets opportunities in the advanced wound care
marketplace, announces several recent appointments of key personnel
at its subsidiary, HemCon Medical Technologies, Inc. to complete
its transition to exclusively focus the company resources on
marketing and sales, new product development and technological
innovations, best of class regulatory and quality systems. The
company has successfully completed their physical move to new
facilities in downtown Portland,
Oregon and transferred all manufacturing to U.S.-based world
class outsourcing partners.
Photo -
http://photos.prnewswire.com/prnh/20150216/175782LOGO
Photo -
http://photos.prnewswire.com/prnh/20150216/175783LOGO
In related news, Simon McCarthy,
formerly the Chief Scientific Officer, has been promoted to the new
position of Science and Technology Fellow at HemCon Medical
Technologies, Inc.
Dr. McCarthy brings over 25 years of research experience in
chemistry and holds multiple worldwide patents in the chemistry and
medical device field. He joined HemCon in 2001 as one of the
primary founders and inventors of the underlying technology
utilized in the life-saving HemCon wound care solutions. Simon was
named in 2005 by the US Army as a Top Ten Invention Award recipient
in 2005 for invention & development of the HemCon Chitosan
Bandage. He further won the Tibbets Award in 2007 for development
of the HemCon Bandage and was the finalist in Australia Eureka Awards 2012 for development
of the novel co-polyurethane-siloxane Elast-Eon. In his new role,
Dr. McCarthy, a corporate officer, will have a broad mandate in all
scientific and technological matters across the company reporting
directly to the President and CEO.
Stuart Sands, currently Chief
Financial Officer has been appointed the company's Chief Operating
Officer as well. Mr. Sands was instrumental in planning and
executing the transition of HemCon operations toward an efficient
wound care enterprise. His leadership during this critical phase of
development has directly contributed toward building what the
company believes will be a profitable company in 2015. The company
has previously announced that beginning in January 2015 it will be selling its manufacturing
assets and focusing exclusively on marketing, sales and new product
development utilizing established US manufacturing outsourcing
partners. With the complex restructuring task complete, Mr. Sands
will now direct the new manufacturing systems and corporate wide
business operations.
Dr. Brian Clare, Senior Scientist
has been promoted to Vice President of Innovation. Both research
& development and new product development will now report to
Dr. Clare. "As a materials scientist Brian has a unique ability to
contribute to the innovation process both in continuous product
improvement and applying new technological solutions," said
Michael Wax, President and
CEO. Following Dr. Clare's Chemistry PhD from the
University of Wisconsin he has worked
in diverse leadership technology roles including, Principal
Investigator, Senior Project Engineer & Polymer Chemist as well
Director of Technology. During the transition at HemCon, Dr. Clare
successfully directed the technical transfer process.
Dr. Maire Ni Beilliu, has been promoted to Vice President of
Regulatory Affairs & Quality Systems. At HemCon Europe,
before relocating to Portland,
Oregon headquarters, Dr. Ni Beilliu held the senior
management position. She joined the European company in 2007. She
now will be responsible for the regulatory component of our medical
device business, with additional responsibility for directing the
company's U.S.-based quality operation. Her firsthand
knowledge of the HemCon subsidiary in the Czech Republic will be applied as the company
plans to expand its international footprint. A trained scientist,
with a Ph.D. in biochemistry and invaluable experience on the
European side of our operations, Dr. Ni Beilliu is uniquely
qualified to establish the policies HemCon requires to thrive in an
increasingly regulated worldwide industry.
Michael Wax, President and CEO
said, "These organizational changes are the first in our plan to
create a knowledge based company composed of talented employees
capable of leading us along a profitable fast growing pathway. The
entire team is looking ahead to 2015 with excitement as HemCon
embarks on its operating mission to build a profitable wound care
company for many years into the future," said Wax.
About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops,
manufactures, and markets innovative technologies for hemostatic
devices for the control of bleeding resulting from trauma or
surgery. HemCon products are designed for use by military and
civilian first responders as well as medical professionals in
hospital and clinical settings where control of bleeding are of
critical importance. HemCon is headquartered in Portland, Ore. The Company has subsidiaries in
Ireland and the Czech Republic. For more information, please
visit www.hemcon.com.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI) is a
health and wellness company that targets opportunities in the
advanced wound care marketplace. TriStar is the owner of HemCon
Medical Technologies Inc., a company dedicated to saving lives
through innovative wound care solutions.
Forward-Looking Statement
This press release for TriStar Wellness Solutions®, Inc.
contains forward-looking statements. Generally, you can identify
these statements because they use words like "anticipates,"
"believes," "expects," "future," "intends," "plans," and similar
terms. These statements reflect only our current expectations.
Although we do not make forward-looking statements unless we
believe we have a reasonable basis for doing so, we cannot
guarantee their accuracy and actual results may differ materially
from those we anticipated due to a number of uncertainties, many of
which are unforeseen, including, among others, the risks we face as
described our filings with the Securities and Exchange Commission.
You should not place undue reliance on these forward-looking
statements which apply only as of the date of this press release.
To the extent that such statements are not recitations of
historical fact, such statements constitute forward-looking
statements that, by definition, involve risks and uncertainties. In
any forward-looking statement where we express an expectation or
belief as to future results or events, such expectation or belief
is expressed in good faith and believed to have a reasonable basis,
but there can be no assurance that the statement of expectation of
belief will be accomplished.
Contact:
Stephanie
Wiegman
Tel: (503) 245-0459
Email
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hemcon-medical-technologies-continues-transition-to-innovation-leader-300036607.html
SOURCE TriStar Wellness Solutions, Inc.
